CD68 and triple-negative breast carcinoma: Similar to findings in this study, CD68+ TAMs did not significantly correlate with overall survival and recurrence-free survival (RFS) in multivariate analysis in basal-like breast cancer (BLBC) and triple-negative cancer of the breast (24, 69).